Morgan Stanley’s Checkmate Pharmaceuticals, Inc. Common Stock CMPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-3,005
| Closed | -$10K | – | 8264 |
|
|
2022
Q1 | $10K | Sell |
3,005
-1,070
| -26% | -$3.56K | ﹤0.01% | 7423 |
|
|
2021
Q4 | $12K | Sell |
4,075
-45
| -1% | -$133 | ﹤0.01% | 7431 |
|
|
2021
Q3 | $16K | Buy |
4,120
+3,728
| +951% | +$14.5K | ﹤0.01% | 7186 |
|
|
2021
Q2 | $2K | Buy |
392
+69
| +21% | +$352 | ﹤0.01% | 7569 |
|
|
2021
Q1 | $4K | Sell |
323
-3,427
| -91% | -$42.4K | ﹤0.01% | 7186 |
|
|
2020
Q4 | $55K | Buy |
3,750
+3,000
| +400% | +$44K | ﹤0.01% | 6137 |
|
|
2020
Q3 | $9K | Buy |
+750
| New | +$9K | ﹤0.01% | 6318 |
|